一种杂交-杂交单克隆抗体与长春碱对已建立的肿瘤异种移植瘤的抑制作用。
Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine.
作者信息
Smith W, Gore V A, Brandon D R, Lynch D N, Cranstone S A, Corvalan J R
机构信息
Lilly Research Centre Ltd, Eli Lilly & Co., Windlesham, Surrey, United Kingdom.
出版信息
Cancer Immunol Immunother. 1990;31(3):157-63. doi: 10.1007/BF01744730.
Abstract
The hybrid-hybrid monoclonal antibody 28-19-8 has specificity for the tumour-associated antigen carcinoembryonic antigen and the vinca alkaloids. This bifunctional antibody has been used to target unmodified vinblastine sulphate to well-established MAWI human tumour xenografts implanted in nude mice. The highly significant suppression of tumour growth achieved throughout treatment has also been sustained for over 2 months after the withdrawal of treatment. Histological examination of excised tumours from treated animals has shown profound changes in their morphology when compared with tumours from control animals. Cells in tumours that had started to grow again after withdrawal of therapy were shown still to express carcinoembryonic antigen, the target antigen recognised by the bispecific antibody.
摘要
杂交-杂交单克隆抗体28-19-8对肿瘤相关抗原癌胚抗原和长春花生物碱具有特异性。这种双功能抗体已被用于将未修饰的硫酸长春碱靶向植入裸鼠体内的成熟MAWI人肿瘤异种移植物。在整个治疗过程中实现的肿瘤生长的高度显著抑制在停止治疗后也持续了2个多月。与对照动物的肿瘤相比，对治疗动物切除肿瘤的组织学检查显示其形态发生了深刻变化。在停止治疗后再次开始生长的肿瘤中的细胞仍显示表达癌胚抗原，即双特异性抗体识别的靶抗原。
相似文献
1
Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine.一种杂交-杂交单克隆抗体与长春碱对已建立的肿瘤异种移植瘤的抑制作用。
Cancer Immunol Immunother. 1990;31(3):157-63. doi: 10.1007/BF01744730.
2
Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody.一种双杂交单克隆抗体靶向肿瘤提高长春花生物碱的治疗效果。
Cancer Immunol Immunother. 1987;24(2):138-43. doi: 10.1007/BF00205591.
3
Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.使用一种既识别癌胚抗原（CEA）又识别长春花生物碱的杂交-杂交单克隆抗体，实现药物在体外和体内对肿瘤细胞的特异性定位。
Cancer Immunol Immunother. 1987;24(2):133-7. doi: 10.1007/BF00205590.
4
Tumour therapy with Vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and Vinca alkaloids.
Int J Cancer Suppl. 1988;2:22-5. doi: 10.1002/ijc.2910410708.
5
Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice.双特异性抗蓖麻毒素A链：抗癌胚抗原单克隆抗体预先靶向裸鼠人胃癌异种移植瘤对重组蓖麻毒素A链的捕获
J Cancer Res Clin Oncol. 1992;118(5):367-70. doi: 10.1007/BF01294441.
6
The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.单克隆抗体在结直肠癌异种移植瘤中对癌胚抗原的比较分布。
Tumour Biol. 1984;5(5):255-61.
7
A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma.伊马替尼抑制血小板衍生生长因子受体（PDGFR）对两种病理特征不同的结肠腺癌模型中放射性标记抗体靶向性和清除率影响的比较研究。
Tumour Biol. 2012 Dec;33(6):2019-29. doi: 10.1007/s13277-012-0461-9. Epub 2012 Jul 26.
8
In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen.
Bioconjug Chem. 1992 Jul-Aug;3(4):315-22. doi: 10.1021/bc00016a010.
9
In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.三种不同亚类的单克隆抗体-药物偶联物的体内疗效，这些偶联物可结合由KS1/4单克隆抗体定义的人类肿瘤相关抗原。
Cancer Immunol Immunother. 1989;28(3):171-8. doi: 10.1007/BF00204985.
10
Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice.热疗与碘-131标记的抗癌胚抗原单克隆抗体对裸鼠人肿瘤异种移植瘤的影响。
Cancer. 1992 Dec 15;70(12):2785-91. doi: 10.1002/1097-0142(19921215)70:12<2785::aid-cncr2820701210>3.0.co;2-i.
引用本文的文献
1
Strategies in antibody therapy of cancer.癌症抗体治疗策略。
Clin Exp Immunol. 1990 Nov;82(2):189-93. doi: 10.1111/j.1365-2249.1990.tb05425.x.
2
Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.用于两阶段放射免疫治疗的双特异性单克隆抗体的生成
Br J Cancer. 1991 May;63(5):681-6. doi: 10.1038/bjc.1991.155.
3
Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.用于癌症治疗的异种单克隆抗体：通过抗体 - 药物免疫偶联物控制其体内免疫原性并诱导特异性无反应性
Br J Cancer. 1991 Aug;64(2):281-7. doi: 10.1038/bjc.1991.292.
本文引用的文献
1
Hybrid hybridomas and the production of bi-specific monoclonal antibodies.杂交杂交瘤与双特异性单克隆抗体的产生
Immunol Today. 1984 Oct;5(10):299-304. doi: 10.1016/0167-5699(84)90155-5.
2
Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.用于定位接种于裸鼠的人结肠癌的抗癌胚抗原单克隆抗体的放射性标记片段。
J Exp Med. 1983 Aug 1;158(2):413-27. doi: 10.1084/jem.158.2.413.
3
Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.长春地辛-抗癌胚抗原缀合物在晚期癌症患者中的定位及毒性研究
Br J Cancer. 1983 Jan;47(1):35-42. doi: 10.1038/bjc.1983.4.
4
A comparison of the content and immunohistochemical patterns of CEA-like activity in human colorectal tumours and nude mouse xenografts.人结肠肿瘤和裸鼠异种移植瘤中癌胚抗原样活性的含量及免疫组化模式比较
Exp Pathol. 1983;24(4):227-35. doi: 10.1016/s0232-1513(83)80010-3.
5
Therapeutic potential of monovalent monoclonal antibodies.单价单克隆抗体的治疗潜力。
Nature. 1984;308(5958):460-2. doi: 10.1038/308460a0.
6
The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.单克隆抗体在结直肠癌异种移植瘤中对癌胚抗原的比较分布。
Tumour Biol. 1984;5(5):255-61.
7
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.单克隆抗体在人类恶性肿瘤组织病理学诊断中的应用。
J Clin Pathol. 1982 Nov;35(11):1253-67. doi: 10.1136/jcp.35.11.1253.
8
Hybrid hybridomas and their use in immunohistochemistry.杂交杂交瘤及其在免疫组织化学中的应用。
Nature. 1983;305(5934):537-40. doi: 10.1038/305537a0.
9
Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.抗癌胚抗原单克隆抗体在结直肠癌异种移植瘤中的定位
Cancer Immunol Immunother. 1985;19(1):8-17. doi: 10.1007/BF00199305.
10
Antitumor properties of vindesine-monoclonal antibody conjugates.长春地辛-单克隆抗体偶联物的抗肿瘤特性。
Cancer Immunol Immunother. 1985;19(1):1-7. doi: 10.1007/BF00199304.
Zotero 插件